Artificial Intelligence–Powered Prediction of <i>ALK</i> Gene Rearrangement in Patients With Non–Small-Cell Lung Cancer

Yukihiro Terada(Shinshu University), Toshiaki Takahashi(Okayama University)

JCO Clinical Cancer Informatics

September 26, 2022

10.1200/cci.22.00070

Cited by 9

Related Papers

Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation

|New England Journal of Medicine|2021|1.8k

Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC

|New England Journal of Medicine|2024|291

Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study

|Journal of Thoracic Oncology|2022|158

Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter

|Cancer Science|2018|42